NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 47 filers reported holding NABRIVA THERAPEUTICS PLC in Q3 2019. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $9,000 | -25.0% | 17,559 | 0.0% | 0.00% | – |
| Q2 2020 | $12,000 | +20.0% | 17,559 | 0.0% | 0.00% | – |
| Q1 2020 | $10,000 | -56.5% | 17,559 | 0.0% | 0.00% | – |
| Q4 2019 | $23,000 | -34.3% | 17,559 | 0.0% | 0.00% | – |
| Q3 2019 | $35,000 | -18.6% | 17,559 | 0.0% | 0.00% | – |
| Q2 2019 | $43,000 | 0.0% | 17,559 | 0.0% | 0.00% | – |
| Q1 2019 | $43,000 | +65.4% | 17,559 | 0.0% | 0.00% | – |
| Q4 2018 | $26,000 | -44.7% | 17,559 | 0.0% | 0.00% | – |
| Q3 2018 | $47,000 | – | 17,559 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 191,028 | $462,000 | 0.08% |
| Sterling Investment Advisors, Ltd. | 5,000 | $12,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |